| Literature DB >> 31065267 |
Peter Andersson1, Luca Pagliani2, Damiano Verrocchi3, Stefano Volpe4, Herman Sahlin5, Lars Sennerby6.
Abstract
BACKGROUND: Diagnostic instruments based on resonance frequency analysis (RFA) can be utilised to assess dental implant stability during treatment and follow-up. AIM: The aim of the present study was to investigate the influence of patient- and implant-related factors on implant stability and the 5-year implant survival. In addition, the influence of stability (ISQ value) at placement and abutment connection on implant survival was evaluated.Entities:
Year: 2019 PMID: 31065267 PMCID: PMC6466959 DOI: 10.1155/2019/3209872
Source DB: PubMed Journal: Int J Dent ISSN: 1687-8728
Number of patients and implants according to gender.
| Patients | Implants | |||
|---|---|---|---|---|
|
| % |
| % | |
| Female | 183 | 55.5 | 434 | 59.0 |
| Male | 147 | 44.5 | 301 | 41.0 |
| Total | 330 | 735 | ||
Information is missing for 4 patients with 10 implants.
Figure 1The design of the Neoss implant used in the study.
Implant lengths and diameters.
| Diameter | Total | ||||||
|---|---|---|---|---|---|---|---|
| 3.5 mm | 4.0 mm | 4.5 mm | 5.0 mm | 5.5 mm | |||
| Length | 7 mm | 5 | 16 | 10 | 0 | 0 | 31 |
| 9 mm | 27 | 98 | 41 | 2 | 8 | 176 | |
| 11 mm | 37 | 118 | 42 | 0 | 5 | 202 | |
| 13 mm | 49 | 126 | 20 | 1 | 2 | 198 | |
| 15 mm | 33 | 86 | 9 | 0 | 0 | 128 | |
| 17 mm | 4 | 3 | 0 | 0 | 0 | 7 | |
| Total | 155 | 447 | 122 | 3 | 15 | 742 | |
Bone quantity and quality according to Ga and Albrektsson [20].
| Bone quantity | |||||||
|---|---|---|---|---|---|---|---|
| A | B | C | D | E | Total | ||
| Bone quality | 1 | 0 | 8 | 22 | 7 | 0 | 37 |
| 2 | 7 | 184 | 191 | 10 | 0 | 392 | |
| 3 | 23 | 104 | 127 | 9 | 0 | 263 | |
| 4 | 0 | 24 | 25 | 1 | 0 | 50 | |
| Total | 30 | 320 | 365 | 27 | 0 | 742 | |
Information is missing for 3 implants.
Figure 2RFA measurement of an implant utilising a SmartPeg™ transducer and an Osstell Mentor™ machine (Osstell AB, Gothenburg, Sweden).
Type of prosthetic constructions.
| Maxilla | Mandible | Total | ||||
|---|---|---|---|---|---|---|
|
| % |
| % |
| % | |
| Single | 86 | 46.2 | 79 | 40.7 | 165 | 43.4 |
| Partial | 86 | 46.2 | 94 | 48.5 | 180 | 47.4 |
| Full arch, fixed | 14 | 7.5 | 5 | 2.6 | 19 | 5.0 |
| Full arch, overdenture | 0 | 0 | 16 | 8.2 | 16 | 4.2 |
| Total | 186 | 194 | 380 | |||
Number of implants per type of construction.
| Maxilla | Mandible | Total | ||||
|---|---|---|---|---|---|---|
|
| % |
| % |
| % | |
| Single | 86 | 23.4 | 79 | 21.0 | 165 | 22.2 |
| Partial | 212 | 57.8 | 240 | 63.8 | 452 | 60.8 |
| Full | 69 | 18.8 | 57 | 15.2 | 126 | 17.0 |
| Total | 367 | 376 | 743 | |||
Information is missing for 2 implants.
Implant survival.
| Interval | Implants | Failed | Withdrawn | CSR (%) |
|---|---|---|---|---|
| Insertion to loading | 745 | 8 | 2 | 98.9 |
| Loading to 5 years | 735 | 12 | 11 | 97.3 |
| 5 years | 712 | — | — | 97.3 |
CSR: cumulative survival rate.
Analyses of implant stability at implant insertion.
| Variable | Groups | Implants placed | ISQ | Significance test | |
|---|---|---|---|---|---|
| Mean | SD | ||||
| Age | 10–19 | 7 | 75.1 | 6.8 |
|
| 20–29 | 7 | 75.7 | 6.7 | ||
| 30–39 | 61 | 74.2 | 6.8 | ||
| 40–49 | 164 | 74.4 | 7.0 | ||
| 50–59 | 210 | 72.9 | 8.9 | ||
| 60–69 | 169 | 73.2 | 7.9 | ||
| 70–79 | 33 | 72.6 | 6.1 | ||
| 80–89 | 2 | 77.0 | 2.8 | ||
|
| |||||
| Gender | Female | 381 | 72.8 | 8.1 |
|
| Male | 264 | 74.7 | 7.3 | ||
|
| |||||
| Jaw | Maxilla | 304 | 71.3 | 8.4 |
|
| Mandible | 351 | 75.5 | 6.8 | ||
|
| |||||
| Position | Anterior | 148 | 72.3 | 8.5 |
|
| Posterior | 506 | 73.9 | 7.6 | ||
|
| |||||
| Indication | Single | 142 | 73.9 | 8.3 |
|
| Partial | 398 | 74.0 | 7.2 | ||
| Full | 113 | 71.6 | 9.2 | ||
|
| |||||
| Bone quantity | A | 25 | 74.1 | 7.5 |
|
| B | 277 | 74.0 | 8.0 | ||
| C | 325 | 73.3 | 7.5 | ||
| D | 27 | 70.3 | 10.3 | ||
| E | 0 | — | — | ||
|
| |||||
| Bone quality | 1 | 35 | 76.5 | 6.4 |
|
| 2 | 354 | 75.2 | 7.0 | ||
| 3 | 224 | 72.0 | 7.0 | ||
| 4 | 41 | 63.8 | 10.7 | ||
|
| |||||
| Implant diameter | 3.5 mm | 147 | 73.1 | 7.6 |
|
| 4.0 mm | 373 | 73.4 | 7.3 | ||
| 4.5 mm | 117 | 75.1 | 8.5 | ||
| 5.0 mm | 2 | 66.5 | 19.1 | ||
| 5.5 mm | 15 | 70.9 | 12.9 | ||
|
| |||||
| Implant length | 7 mm | 28 | 71.0 | 9.1 |
|
| 9 mm | 164 | 73.8 | 7.3 | ||
| 11 mm | 186 | 74.4 | 6.7 | ||
| 13 mm | 179 | 73.8 | 8.1 | ||
| 15 mm | 92 | 71.5 | 9.4 | ||
| 17 mm | 5 | 76.0 | 6.4 | ||
(1)Kruskal–Wallis test; (2)Mann–Whitney U-test; (3)pairwise Mann–Whitney U-tests (Bonferroni-corrected significance levels).
Analyses of implant stability at abutment connection or prosthetic loading.
| Variable | Groups | Implants | ISQ | Significance test | |
|---|---|---|---|---|---|
| Placed | Mean | SD | |||
| Age | 10–19 | 5 | 80.6 | 7.2 |
|
| 20–29 | 6 | 77.5 | 5.4 | ||
| 30–39 | 45 | 75.9 | 5.2 | ||
| 40–49 | 144 | 74.3 | 6.8 | ||
| 50–59 | 154 | 75.2 | 6.4 | ||
| 60–69 | 140 | 74.9 | 7.0 | ||
| 70–79 | 31 | 76.6 | 4.4 | ||
| 80–89 | 2 | 77.0 | 8.5 | ||
|
| |||||
| Gender | Female | 322 | 74.7 | 6.9 |
|
| Male | 204 | 75.9 | 5.7 | ||
|
| |||||
| Jaw | Maxilla | 245 | 74.1 | 6.6 |
|
| Mandible | 284 | 76.0 | 6.3 | ||
|
| |||||
| Position | Anterior | 112 | 74.8 | 6.6 |
|
| Posterior | 416 | 75.1 | 6.5 | ||
|
| |||||
| Indication | Single | 78 | 74.7 | 7.9 |
|
| Partial | 333 | 75.0 | 6.2 | ||
| Full | 117 | 75.7 | 6.2 | ||
|
| |||||
| Bone quantity | A | 20 | 76.7 | 5.9 |
|
| B | 210 | 75.1 | 6.7 | ||
| C | 279 | 75.1 | 6.4 | ||
| D | 19 | 73.1 | 6.5 | ||
| E | 0 | — | — | ||
|
| |||||
| Bone quality | 1 | 23 | 76.6 | 5.6 |
|
| 2 | 284 | 75.8 | 6.5 | ||
| 3 | 183 | 74.2 | 6.2 | ||
| 4 | 38 | 73.5 | 8.3 | ||
|
| |||||
| Implant diameter | 3.5 mm | 106 | 74.1 | 6.7 |
|
| 4.0 mm | 310 | 74.8 | 6.4 | ||
| 4.5 mm | 100 | 76.9 | 6.5 | ||
| 5.0 mm | 2 | 77.5 | 3.5 | ||
| 5.5 mm | 10 | 77.8 | 6.2 | ||
|
| |||||
| Implant length | 7 mm | 25 | 73.5 | 6.7 |
|
| 9 mm | 144 | 75.1 | 6.9 | ||
| 11 mm | 151 | 75.6 | 5.9 | ||
| 13 mm | 127 | 75.0 | 6.6 | ||
| 15 mm | 76 | 75.1 | 6.6 | ||
| 17 mm | 5 | 70.8 | 7.5 | ||
(1)Kruskal–Wallis test; (2)Mann–Whitney U-test; (3)pairwise Mann–Whitney U-tests (Bonferroni-corrected significance levels).
Analyses of implant survival.
| Variable | Groups | Implants | Implant failures | CSR (%) | Significance test | |
|---|---|---|---|---|---|---|
| Placed | Overall | Early/late | ||||
| Age | 10–19 | 7 | 0 | — | 100 |
|
| 20–29 | 7 | 0 | — | 100 | ||
| 30–39 | 70 | 2 | 2/0 | 97.1 | ||
| 40–49 | 186 | 2 | 1/1 | 98.9 | ||
| 50–59 | 240 | 9 | 5/4 | 96.3 | ||
| 60–69 | 192 | 7 | 0/7 | 96.4 | ||
| 70–79 | 38 | 0 | — | 100 | ||
| 80–89 | 3 | 0 | — | 100 | ||
|
| ||||||
| Gender | Female | 434 | 13 | 5/8 | 97.0 |
|
| Male | 301 | 7 | 3/4 | 97.7 | ||
|
| ||||||
| Jaw | Maxilla | 368 | 14 | 7/7 | 96.2 |
|
| Mandible | 377 | 6 | 1/5 | 98.4 | ||
|
| ||||||
| Position | Anterior | 172 | 7 | 3/4 | 95.9 |
|
| Posterior | 572 | 13 | 5/8 | 97.7 | ||
|
| ||||||
| Indication | Single | 165 | 5 | 1/4 | 97.0 |
|
| Partial | 452 | 7 | 5/2 | 98.5 | ||
| Full | 126 | 8 | 2/6 | 93.7 | ||
|
| ||||||
| Bone quantity | A | 30 | 0 | — | 100 |
|
| B | 320 | 5 | 4/1 | 98.4 | ||
| C | 365 | 13 | 4/9 | 96.4 | ||
| D | 27 | 2 | 0/2 | 92.6 | ||
| E | 0 | 0 | — | — | ||
|
| ||||||
| Bone quality | 1 | 37 | 0 | — | 100 |
|
| 2 | 392 | 11 | 4/7 | 97.2 | ||
| 3 | 263 | 8 | 4/4 | 97.0 | ||
| 4 | 50 | 1 | 0/1 | 98.0 | ||
|
| ||||||
| Implant diameter | 3.5 mm | 155 | 7 | 2/5 | 95.5 |
|
| 4.0 mm | 447 | 10 | 6/4 | 97.8 | ||
| 4.5 mm | 122 | 2 | 0/2 | 98.4 | ||
| 5.0 mm | 3 | 0 | — | 100 | ||
| 5.5 mm | 15 | 1 | 0/1 | 93.3 | ||
|
| ||||||
| Implant length | 7 mm | 31 | 1 | 0/1 | 96.8 |
|
| 9 mm | 176 | 7 | 2/5 | 96.0 | ||
| 11 mm | 202 | 4 | 1/3 | 98.0 | ||
| 13 mm | 198 | 7 | 4/3 | 96.5 | ||
| 15 mm | 128 | 1 | 1/0 | 99.2 | ||
| 17 mm | 7 | 0 | — | 100 | ||
|
| ||||||
| ISQ at insertion | <50 | 7 | 1 | 1/0 | 85.7 |
|
| 50–59 | 32 | 1 | 0/1 | 96.9 | ||
| 60–69 | 112 | 8 | 1/7 | 92.9 | ||
| 70–79 | 346 | 9 | 5/4 | 97.4 | ||
| 80–89 | 158 | 0 | — | 100 | ||
|
| ||||||
| ISQ at loading | <50 | 0 | 0 | 0/0 | — |
|
| 50–59 | 6 | 0 | 0/0 | 100 | ||
| 60–69 | 95 | 7 | 0/7 | 92.6 | ||
| 70–79 | 267 | 4 | 0/4 | 98.5 | ||
| 80–89 | 161 | 1 | 0/1 | 99.4 | ||
(1)Pearson chi-square; (2)Fisher's exact test; (3)pairwise Fisher's exact tests (Bonferroni-corrected significance levels).
Implant survival below and above at different threshold values at implant insertion and loading.
| Variable | Groups | Implants placed | Implant failures | CSR(1) (%) | Odds ratio | 95% C.I. |
| |
|---|---|---|---|---|---|---|---|---|
| Overall | Early/late | |||||||
| ISQ at insertion | <60 | 39 | 2 | 1/1 | 94.9 | 1.90 | 0.4–8.6 | 0.314(1) |
| ≥60 | 616 | 17 | 6/11 | 97.2 | 1 | |||
|
| ||||||||
| ISQ at loading | <60 | 6 | 0 | 0/0 | 100 | N/A | N/A | 1.0(1) |
| ≥60 | 523 | 12 | 0/12 | 97.7 | ||||
|
| ||||||||
| ISQ at insertion | <65 | 83 | 5 | 1/4 | 94.0 | 2.56 | 0.9–7.3 | 0.080(1) |
| ≥65 | 572 | 14 | 6/8 | 97.6 | 1 | |||
|
| ||||||||
| ISQ at loading | <65 | 42 | 2 | 0/2 | 95.2 | 2.39 | 0.5–11.2 | 0.245(1) |
| ≥65 | 487 | 10 | 0/10 | 97.9 | 1 | |||
|
| ||||||||
| ISQ at insertion | <70 | 151 | 10 | 2/8 | 93.4 | 3.90 | 1.6–9.7 | 0.004(1) |
| ≥70 | 504 | 9 | 5/4 | 98.2 | 1 | |||
|
| ||||||||
| ISQ at loading | <70 | 101 | 7 | 0/7 | 93.1 | 6.30 | 1.9–20.2 | 0.003(1) |
| ≥70 | 428 | 5 | 0/5 | 98.8 | 1 | |||
|
| ||||||||
| ISQ at insertion | <75 | 293 | 16 | 6/10 | 94.5 | 6.90 | 2.0–23.8 | 0.001(1) |
| ≥75 | 362 | 3 | 1/2 | 99.2 | 1 | |||
|
| ||||||||
| ISQ at loading | <75 | 207 | 11 | 0/11 | 94.7 | 17.9 | 2.3–142.9 | <0.001(1) |
| ≥75 | 322 | 1 | 0/1 | 99.7 | 1 | |||
CSR: cumulative survival rate; (1)Fisher's exact test.
Figure 3Failure rates for implants with values < or ≥60, 65, 70, and 75 ISQ at placement and loading. Note. There is a consistent correlation between failure and stability for implants above the threshold levels at placement and loading (see Table 10 for statistical analyses).